VU6033685
VU6033685 is the orally active positive allosteric modulator (PAM) for mGlu1 that positively modulates human mGlu1 and human mGlu5 with EC50 of 39 nM and 3960 nM. VU6033685 also inhibits CYP1A2, CYP2C9 and CYP2D6 with IC50 of 26, 22.3 and 23.8 μM, respectively. VU6033685 reverses amphetamine-induced rats hyperlocomotion, protects rats from MK-801 -induced cognitive impairment. VU6033685 exhibits good pharmacokinetics characteristics in rats with an oral bioavailability of 42.8%[1].
Product Specifications
UNSPSC
12352005
Target
MGluR
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
CC1=NC(C2CC2)=CC=C1CNC(C3=CC(N4C=CC=N4)=CC=C3Cl)=O
Molecular Formula
C20H19ClN4O
Molecular Weight
366.84
References & Citations
[1]Reed CW, et al., Further Optimization of the mGlu1 PAM VU6024578/BI02982816: Discovery and Characterization of VU6033685. ACS Chem Neurosci. 2025 Feb 19;16 (4) :745-752.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881815-100 1x 100 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (CHGA/1815R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472040-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (Pituitary Marker) (CLIP/2040R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details